Trial intelligence / Profile preview

Effect of tesofensine on weight reduction in obese patients

2006-002862-20Phase 2Completed

Sponsor
NeuroSearch
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in obesity comparing Tesofensine with Placebo (2 arms). Primary endpoints: Change in body weight (absolute) and Change in body weight (percent). Started Jul 2006; status: completed.

02

Drugs

tesofensine
03

Conditions

obesity

Beyond the preview

Go deeper on 2006-002862-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002862-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call